Cardiovascular Imaging, Heart Disease and Technology

Cleerly Raises $106 Million in Series C Extension Funding

DAIC

DECEMBER 5, 2024

Cleerly is dedicated to creating a new standard of care for heart disease by using FDA-cleared solutions powered by artificial intelligence. Cleerly’s pioneering approach to advanced cardiovascular imaging, powered by AI-driven analysis, is elevating the field of diagnostic tools for coronary artery disease.

Coronary Artery Disease

Coronary Artery Disease Medicare Technology Plaque

Phoenix Cardiology Practice Installs the First and Fastest Cardiovascular CT Scanner in the State, Arineta’s SpotLight Duo

DAIC

JULY 16, 2024

mtaschetta-millane Tue, 07/16/2024 - 09:59 July 16, 2024 — Arineta , a leader in advancing cardiovascular imaging solutions through cutting-edge technology, proudly announces the latest installation of its SpotLight Duo at Cardiovascular Consultants, Ltd. (CVC) CVC) in Arizona. sec per rotation.

Technology

Technology Cardiovascular Imaging Heart Disease Cardiovascular Disease

Artificial Intelligence Helps Coronary CT Angiography and Accelerates the Development of Precision Medicine

DAIC

JANUARY 17, 2024

Christian Tesche (Division of Cardiovascular Imaging, Department of Radiology and Radiological Science, Medical University of South Carolina and Department of Cardiology, Munich University Clinic, Ludwig-Maximilian-University).

Technology

Technology Coronary Artery Disease Cardiovascular Disease Cardiovascular Imaging

Society of Cardiovascular Computed Tomography Annual Scientific Meeting SCCT24 Preview

DAIC

JUNE 27, 2024

Attendees can join with their peers and participate in sessions on structural heart disease, congenital heart disease, guidelines and trials, AI/Machine learning, technical aspects of cardiac CT, coronary artery disease, vascular heart disease, debates and games and early career topics.

Congenital Heart Disease

Congenital Heart Disease Coronary Artery Disease Congenital Heart Disease

GE HealthCare and Medis Medical Imaging Announce Collaboration Focused on Non-Invasive Coronary Assessments to Help Advance Precision Care in Treatment of Coronary Artery Disease

DAIC

MAY 14, 2024

The collaboration seeks to provide access to emerging technologies, like Medis QFR, while also reducing complexity in the cath lab to improve the operating environment for clinicians. Medis Medical Imaging has been developing innovative post-processing software for the quantification of cardiovascular images for thirty-five years.

Coronary Artery Disease

Coronary Artery Disease Interventional Cardiology Innovation Physiology

Robust Diagnostic Accuracy and Prognostic Utility in Analyses from Large Scale Clinical Trials

DAIC

MARCH 28, 2024

milla1cf Thu, 03/28/2024 - 07:00 March 28, 2024 — Cleerly , the company on a mission to create a new standard of care to aid in the diagnosis of heart disease, shared findings from a study published online in the Journal of the American College of Cardiology: Cardiovascular Imaging on March 13, 2024.

Ischemia

Ischemia Chest Pain Atherosclerosis Coronary Artery Disease

Results of CERTAIN Study Demonstrate Prominent Effects of Cleerly Products on Changing Clinical Management for Patients Suspected of Coronary Artery Disease

DAIC

FEBRUARY 13, 2024

Cleerly, a digital healthcare company focused on heart disease, has announced continued strong scientific evidence supporting the clinical utility of its products, detailing a study published online on Jan. 25, 2024 in the European Heart Journal Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging.

Coronary Artery Disease

Coronary Artery Disease Ischemia Atherosclerosis Cardiovascular Imaging

Fellowship Programs Demystified: Why and When You Should Consider a Fellowship

ADN Center of Excellence

NOVEMBER 14, 2024

Access to Cutting-Edge Techniques Many fellowships expose participants to the latest technologies and innovations in their field. From advanced imaging techniques in cardiology to minimally invasive surgical methods in oncology, fellows are often at the forefront of medical advancements. Here are a few examples: 1.

Academic

Academic Interventional Cardiology Private Practice Innovation

Results Involving Philips FDA-cleared AI-enabled Cardiovascular Ultrasound Platform to be Presented at American Society of Echocardiography Scientific Sessions, ASE 2024

DAIC

JUNE 12, 2024

Image courtesy: Philips christine.book Wed, 06/12/2024 - 14:07 June 12, 2024 — Royal Philips has announced its next-generation AI-enabled cardiovascular ultrasound platform to help speed up cardiac ultrasound analysis with proven AI technology and reduce the burden on echocardiography labs.

Ultrasound

Ultrasound Cardio Oncology Technology Congenital Heart Disease

American Society of Echocardiography Scientific Sessions ASE 2024 Program Highlights

DAIC

JUNE 4, 2024

Six Science & Technology Theater presentations by industry in the Echo Expo. • The conference schedule was designed so participants can explore the latest advancements and share groundbreaking research, while engaging in stimulating educational discussions that will shape the future of cardiovascular imaging.

Ultrasound

Ultrasound Education Research Technology

HeartFlow's Plaque Analysis Leading The Way: 95% Accuracy vs Invasive Imaging In Newly Published REVEALPLAQUE Study

DAIC

MAY 23, 2024

a leader in non-invasive artificial intelligence (AI) heart care solutions, announced that the data from its REVEALPLAQUE study , highlighting the accuracy of its Plaque Analysis, was published in the European Heart Journal Cardiovascular Imaging. 1 Heart disease is the leading cause of death for both men and women.²

Plaque

Plaque Coronary Artery Disease Technology Anatomy

Abbott Announces FDA Approval of First-of-its-kind Device to Repair Leaky Tricuspid Heart Valve, TriClip

DAIC

APRIL 2, 2024

approval of TriClip is a significant advancement for people suffering from tricuspid regurgitation, a heart condition that negatively impacts their quality of life and puts them at grave risk of serious health issues," said Paul Sorajja, M.D. , the Roger L. and Lynn C.

Tricuspid

Tricuspid Heart Valves Quality of Life Open-Heart Surgery

Cardiovascular Update

Cleerly Raises $106 Million in Series C Extension Funding

Phoenix Cardiology Practice Installs the First and Fastest Cardiovascular CT Scanner in the State, Arineta’s SpotLight Duo

Artificial Intelligence Helps Coronary CT Angiography and Accelerates the Development of Precision Medicine

Society of Cardiovascular Computed Tomography Annual Scientific Meeting SCCT24 Preview

GE HealthCare and Medis Medical Imaging Announce Collaboration Focused on Non-Invasive Coronary Assessments to Help Advance Precision Care in Treatment of Coronary Artery Disease

Robust Diagnostic Accuracy and Prognostic Utility in Analyses from Large Scale Clinical Trials

Results of CERTAIN Study Demonstrate Prominent Effects of Cleerly Products on Changing Clinical Management for Patients Suspected of Coronary Artery Disease

Fellowship Programs Demystified: Why and When You Should Consider a Fellowship

Results Involving Philips FDA-cleared AI-enabled Cardiovascular Ultrasound Platform to be Presented at American Society of Echocardiography Scientific Sessions, ASE 2024

American Society of Echocardiography Scientific Sessions ASE 2024 Program Highlights

HeartFlow's Plaque Analysis Leading The Way: 95% Accuracy vs Invasive Imaging In Newly Published REVEALPLAQUE Study

Abbott Announces FDA Approval of First-of-its-kind Device to Repair Leaky Tricuspid Heart Valve, TriClip

Stay Connected